Following climate consultancy EcoAct’s latest report on climate reporting trends for global companies, EPM speaks to Stuart Lemmon, Managing Director of EcoAct, an Atos company, Northern Europe, to discuss the efforts the biopharma industry is making to become more sustainable and what else needs to be done.
